Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Name
Shahram Mossayebi
Title
Co-founder and CEO of Crypto Quantique
Bio
Dr. Shahram Mossayebi is the co-founder and CEO of Crypto Quantique, a London-based cybersecurity innovator specialising in secure, scalable solutions for embedded IoT devices. With a PhD in Post-Quantum Cryptography from Royal Holloway, University of London, Shahram brings a deep understanding of security challenges in IoT, particularly for high-stakes sectors like medical devices. He co-invented the QDID chip, which employs quantum tunnelling technology to create an unclonable identity, enhancing device security at a fundamental level.
Under his leadership, Crypto Quantique developed QuarkLink, a cross-platform security solution that significantly reduces the time and expertise required for secure device development. Designed with stringent regulatory requirements in mind, QuarkLink streamlines compliance for medical device makers by integrating essential features like secure boot, key management, and firmware updates—vital for meeting FDA, NHS, and EU security standards. Shahram’s vision is to empower medical device companies to implement robust security with greater speed and efficiency, ensuring safe and compliant products that serve both healthcare providers and patients.
Under his leadership, Crypto Quantique developed QuarkLink, a cross-platform security solution that significantly reduces the time and expertise required for secure device development. Designed with stringent regulatory requirements in mind, QuarkLink streamlines compliance for medical device makers by integrating essential features like secure boot, key management, and firmware updates—vital for meeting FDA, NHS, and EU security standards. Shahram’s vision is to empower medical device companies to implement robust security with greater speed and efficiency, ensuring safe and compliant products that serve both healthcare providers and patients.
